|
[1]
|
Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isonietabolic on 18F-FDG PET.Eur J Nucl Med Mol Imaging,2002,29(2):176-182. |
|
[2]
|
Langen KJ,Muhlensiepen H,Holschbach M,et al.Transport mechanisms of 3-[123]iodo-α-methvl-L-tyrosine in a human glioma cell line:comparison with [3H-methy]]-L-methionine.J Nucl Med,2000,41(7):1250-1255. |
|
[3]
|
Kracht LW,Friese M,Herholz K.et al.Methyl-[11C]-L-rnethionine uptake as measured by positron emission tomography correlates to microvessel density in patienls with glioma.Eur J Nucl Med Mol Imaging,2003,30(6):868-873. |
|
[4]
|
Giammarile F,Cinotti LE,Jouvet A,et al.High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications.J Neurooncol,2004,68(3):263-274. |
|
[5]
|
Sunada I,Tsuyuguchi N,Hara M,et al.18F-FDG and 11C-methionine PET in choroid plexus papilloma-report of three cases.Radiat Med,2002,20(2):97-100. |
|
[6]
|
Rau FC,Weber WA,Wester HJ,et al.O-(2-[18F]Fluoroethyl)-L-tyrosine (FET):a tracer for differentiation of tumour from inflammation in murine lymph nodes.Eur J Nucl Med Mol Imaging,2002,29(8):1039-1046. |
|
[7]
|
Kaim AH,Weber B,Kurrer MO,et al.18F-FDC and 18F-FET uptake in experimental soft tissue infection.Eur J Nucl Med Mol Imaging,2002,29(5):648-654. |
|
[8]
|
Weber WA,Wester HJ,Grosu AL,et a l.O-(2-[18FJFluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain tumours:initial results of a comparative study.Eur J Nucl Med Mol Imaging,2000,27(5):542-549. |
|
[9]
|
Floeth FW,Pauleit D,Wittsack HJ,et al.Multimodal metabolic imaging of cerebral gliomas:positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.J Neurosurg,2005,102(2):318-327. |
|
[10]
|
Pauleit D,Stoffels G,Schaden W,et al.PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors:first clinical results.J Nucl Med,2005,46(3):411-416. |
|
[11]
|
Ohtani T,Kurihara H,Ishiachi S,et al.Brain tumour imaging with carbon-11 choline:comparison with FDG PET and gadolinium-enhanced MR imaging.EurJ Nucl Med Mol Imaging,2001,28(11):1664-1670 |
|
[12]
|
Kwee SA,Coel MN,Lim J,et al.Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.J Neuroimaging,2004,14(3):285-289. |
|
[13]
|
Tian M,Zhang H,Oriuchi N,et al.Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.Eur J Nucl Med Mol Imaging,2004,31(8):1064-1072. |
|
[14]
|
Zhang H,Tian M,Oriuchi N,et al.11C-choiine PET for the detection of bone and soft tissue tumours in comparison with FDG PET.Nucl Med Commun,2003,24(3):273-279. |
|
[15]
|
Toyohara J,Waki A,Takamatsu S,et al.Basis of FLT as a cell proliferation marker:comparative uptake studies with [3H]thymidine and [3H]arabinothymidine,and cell-analysis in 22 asynchronously growing tumor cell line.Nucl Med Biol,2002,29(3):281-287. |
|
[16]
|
Rasey JS,Grierson JR,Wiens LW,et al.Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.J Nucl Med,2002,43(9):1210-1217. |
|
[17]
|
Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952. |
|
[18]
|
Jacobs AH,Thomas A,Kracht LW,et al.18F-fluoro-L-tKymidine and 11C methylmethionine as markers of increased transport and proliferation in brain tumors.J Nucl Med,2005,46(12):1948-1958. |
|
[19]
|
Pirotte B,Goldman S,Massager N,et al.Combined use of 18F-fluorodeoxyglucose and 11C methionine in 45 positron emission tomography-guided stereotactic brain biopsies.J Neurosurg,2004,101(3):476-483. |
|
[20]
|
Pirotte B,Goldman S,Massager N,et al.Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.J Nucl Med,2004,45(8); 1293-1298. |
|
[21]
|
Grosu AL,Weber WA,Franz M,et al.Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.Int J Radiat Oncol Biol Phys,2005,63(2):511-519. |
|
[22]
|
Ribom D,Engler H,Blomquist E,et al.Potential significance of (11) C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.Eur J Nucl Med Mol Imaging,2002,29(5):632-640. |
|
[23]
|
Kim S,Chung JK,Im SH,et al.11C-methionine PET as a prognostic marker in patients with glioma:comparison with 18F-FDG PET.Eur J Nucl Med Mol Imaging,2005,32(1):52-59. |
|
[24]
|
Van Laere K,Ceyssens S,Van Calenbergh F,et al.Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma:sensitivity,inter-observer variability and prognostic value.Eur J Nucl Med Mol Imaging,2005,32(1):39-51. |
|
[25]
|
Rachinger W,Goetz C,Popperl G,et a l.Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.Neurosurgery,2005,57(3):505-511 |
|
[26]
|
Chen W,Cloughesy T,Kamdar N,et al.Imaging proliferation in brain tumors with 18F-FLT PET:comparison with 18F-FDG.J Nucl Med,2005,46(6):945-952. |
点击查看大图
下载: